Indefinite Delivery Contract SPE2DR25D2001

The Indefinite Delivery Contract (IDC) SPE2DR25D2001 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The IDC has a ceiling value of $999,999,999 and a period of performance through December 31, 2036. It serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The original solicitation, expected to be issued in March 2024, aims to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet. The contracts will cover brand-name, generic, and specialty pharmaceuticals, as well as related medical commodities such as syringes, vials, and test kits across multiple therapeutic areas. The procurement will be fully competitive, with awards made on a regional basis to at least three different contractors. Amerisourcebergen's IDC with DLA Troop Support Medical is one such award under this program, enabling efficient government procurement of essential medical supplies for military personnel, veterans, and other federal beneficiaries.